首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   584719篇
  免费   32022篇
  国内免费   1037篇
耳鼻咽喉   7973篇
儿科学   19388篇
妇产科学   16718篇
基础医学   85959篇
口腔科学   14606篇
临床医学   46548篇
内科学   120646篇
皮肤病学   14605篇
神经病学   46826篇
特种医学   19773篇
外国民族医学   170篇
外科学   82867篇
综合类   9086篇
现状与发展   1篇
一般理论   237篇
预防医学   46482篇
眼科学   12487篇
药学   41003篇
中国医学   1709篇
肿瘤学   30694篇
  2021年   7623篇
  2020年   4396篇
  2019年   7788篇
  2018年   12436篇
  2017年   8471篇
  2016年   8919篇
  2015年   10004篇
  2014年   12265篇
  2013年   18973篇
  2012年   28364篇
  2011年   28964篇
  2010年   16233篇
  2009年   13854篇
  2008年   25160篇
  2007年   27050篇
  2006年   25713篇
  2005年   25328篇
  2004年   23803篇
  2003年   22197篇
  2002年   21038篇
  2001年   20881篇
  2000年   21377篇
  1999年   18174篇
  1998年   4650篇
  1997年   4080篇
  1996年   3805篇
  1995年   3606篇
  1992年   12000篇
  1991年   11846篇
  1990年   11472篇
  1989年   10938篇
  1988年   10006篇
  1987年   9624篇
  1986年   9114篇
  1985年   8705篇
  1984年   6416篇
  1983年   5492篇
  1982年   3304篇
  1979年   5856篇
  1978年   4239篇
  1977年   3642篇
  1976年   3302篇
  1975年   3820篇
  1974年   4524篇
  1973年   4550篇
  1972年   4221篇
  1971年   4037篇
  1970年   3884篇
  1969年   3649篇
  1968年   3485篇
排序方式: 共有10000条查询结果,搜索用时 62 毫秒
91.
The first COVID-19 vaccination was given in December 2020 and there is an effort to vaccinate the international population on a massive scale. Common side effects from the vaccine include headache and tiredness. Regional lymphadenopathy has been described in relation to other vaccines. We describe two cases of supraclavicular reactive lymphadenopathy presenting in patients who had the COVID vaccination in the ipsilateral arm. Awareness of this diagnosis is important for patients presenting to the neck lump clinic.  相似文献   
92.
Neuroscience and Behavioral Physiology - Objective. To determine the frequency, structure, and severity of cognitive impairments in patients with bipolar affective disorder (BAD) in remission....  相似文献   
93.
94.
Food-grade titanium dioxide (E171) is widely used as a food additive, and it is known that after oral consumption, E171 is translocated into the bloodstream reaching the highest titanium level at 6 h. E171 is accumulated in some organs triggering toxicity, but the effects on the blood parameters after oral consumption have been less studied. Recently, evidence shows that oral exposure to E171 induces behavioral signs of anxiety and depression. The relation between blood alterations and psychiatric disorders has been previously demonstrated. However, the oral exposure to E171 effects on alterations in blood parameters and effects linked to alterations in animal behavior has not been explored. In this short communication, we aimed to investigate the effects of E171 on specific blood parameters (hematocrit, hemoglobin, number of erythrocytes, and leukocytes) and anxiety and compulsive-like behavior in males and females orally exposed to ~5 mg/kg for 4 weeks. The results showed that E171 decreased hematocrit and hemoglobin in male but not in female mice while leukocyte and erythrocyte count remained unaltered. Oral consumption of E171 decreased the levels of anxiety-like behavior in females but not in male mice, while compulsive-like behavior was increased in both male and female mice.  相似文献   
95.
96.
Affinity peptide and protein‐ (APP) based radiotracers are an increasingly popular class of radiotracer in positron emission tomography (PET), which was once dominated by the use of small molecule radiotracers. Radiolabelled monoclonal antibodies (mAbs) are important examples of APPs, yet a preference for smaller APPs, which exhibit fast pharmacokinetics and permit rapid PET aided diagnosis, has become apparent. 18F exhibits favourable physical characteristics for APP radiolabelling and has been described as an ideal PET radionuclide. Notwithstanding, 18F radiolabelling of APP is challenging, and this is echoed in the literature where a number of diverse approaches have been adopted. This review seeks to assess and compare the approaches taken to 18F APP radiolabelling with the intention of highlighting trends within this expanding field. Generic themes have emerged in the literature, namely the use of mild radiolabelling conditions, a preference of site‐specific methodologies with an impetus for short, automated procedures which produce high‐yielding [18F]APPs.  相似文献   
97.
98.
Unpredictable hypertrophic scarring (HS) occurs after approximately 35% of all surgical procedures and causes significant physical and psychological complaints. Parallel to the need to understanding the mechanisms underlying HS formation, a prognostic tool is needed. The objective was to determine whether (systemic) immunological differences exist between patients who develop HS and those who develop normotrophic scars (NS) and to assess whether those differences can be used to identify patients prone to developing HS. A prospective cohort study with NS and HS groups in which (a) cytokine release by peripheral blood mononuclear cells (PBMC) and (b) the irritation threshold (IT) after an irritant (sodium lauryl sulphate) patch test was evaluated. Univariate regression analysis of PBMC cytokine secretion showed that low MCP‐1, IL‐8, IL‐18 and IL‐23 levels have a strong correlation with HS (P < .010‐0.004; AUC = 0.790‐0.883). Notably, combinations of two or three cytokines (TNF‐a, MCP‐1 and IL‐23; AUC: 0.942, Nagelkerke R2: 0.727) showed an improved AUC indicating a better correlation with HS than single cytokine analysis. These combination models produce good prognostic results over a broad probability range (sensitivity: 93.8%, specificity 86.7%, accuracy 90,25% between probability 0.3 and 0.7). Furthermore, the HS group had a lower IT than the NS group and an accuracy of 68%. In conclusion, very fundamental immunological differences exist between individuals who develop HS and those who do not, whereas the cytokine assay forms the basis of a predictive prognostic test for HS formation, the less invasive, easily performed irritant skin patch test is more accessible for daily practice.  相似文献   
99.
100.
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号